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Abstract 
Starting from total pancreatic mRNAs, the classical guinea pig pancreatic lipase was cloned using rapid amplification of 3’ and 5’ cDNA ends. 
Internal oligonucleotide primers were designed from a partial cDNA clone including the region coding for the lid domain. Usmg this strategy, we 
did not amplify the cDNA corresponding to the pancreatic lipase related protein 2 in which the lid domain is deleted. Amino acid sequences of the 
classical guinea pig pancreatic lipase and the related protein 2 were compared based on the primary and tertiary structures of the classical human 
pancreatic lipase. Their distinct physiological roles are discussed in the light of functional amino acid differences. 
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1. Introduction 
Over the last four years, a better understanding of the 
pancreatic lipase (PL) structure/function relationships 
has been reached with the resolution of several three- 
dimensional structures [l-3]. Activation of the lipase at 
a lipid/water interface and binding of colipase can now 
be interpreted at the molecular level. At the same time, 
new pancreatic lipases have been cloned from several 
species [4-71, and it appeared that the PL family could 
be divided into three subgroups according to primary 
structures: (1) classical pancreatic lipases, including the 
well known human and porcine PLs, (2) pancreatic lipase 
related proteins 1, PLRPl, and (3) pancreatic lipase re- 
lated proteins 2, PLRP2 [5]. Whereas the kinetic proper- 
ties and the physiological role of PLRPl remain to be 
investigated, PLRP2 might act as a phospholipase under 
physiological conditions [8]. 
The phospholipase activity of PLRP2 has been dem- 
onstrated in the guinea pig [6], a species in which the 
classical pancreatic phospholipase A2 is missing [9]. The 
guinea pig PLRP2 (GPLRP2) is characterized by a large 
deletion in the so-called lid domain that regulates access 
to the active site of the classical PL [6], and by the fact 
that it does not bind colipase [8]. Using trioctanoin as 
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substrate, it has been shown in vitro that GPLRP2 lipase 
activity is inhibited by increasing bile salt concentration, 
and addition of colipase does not restore the activity [8]. 
Accordingly, GPLRP2 cannot hydrolyze insoluble 
triglycerides in the small intestine where colipase nor- 
mally counteracts the inhibitory effect of bile salts by 
anchoring the lipase at the water/triglyceride interface 
[lo]. On the other hand, GPLRP2 hydrolyzes phosphol- 
ipids associated with bile salts in mixed micelles [6,1 l- 
121. 
The digestion of dietary triglycerides is carried out by 
a classical PL which is also found in the guinea pig 
pancreas [12]. In the present article, we report on the 
cloning of this classical guinea pig pancreatic lipase 
(GPL) cDNA and the comparison of GPL amino acid 
sequence with GPLRP2 and human pancreatic lipase 
(HPL). 
2. Materials and methods 
2.1. Amplification of3’ and 5’ GPL cDNA ends 
Total mRNAs were isolated from guinea pig pancreas using the 
guanidine thiocyanate xtraction procedure [13]. GPL cDNA was ob- 
tained from total mRNAs by the procedure of Frohman [14] for rapid 
bamplification of 3’ and 5’ cDNA ends (RACE, see Fig. 1). 
First strand cDNAs were prepared using heat-denaturated (5min at 
65°C) total mRNAs (3 pg) as the template, Superscript reverse tran- 
scriptase (Life Technologies/G&co BRL, Copenhagen, Denmark), and 
primer #I (100 pmol, see Table 1). Reverse transcription was carried 
out in a total reaction volume of 20 pl for 10 min at room temperature 
and 45 min at 42”C, in presence of RNAsin (20 units, Promega Corp., 
Madison, WI). The cDNA/mRNA heteroduplex was then denaturated 
at 95°C for 10 min and cooled on ice. 
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For 5’ RACE, the single strand cDNAs (from 3 pg of total mRNAs) 
were poly-dC tailed with terminal deoxynucleotidyl transferase (Phar- 
macia LKB, Copenhagen, Denmark). Amplification of the specific 
GPL cDNA 5’ end was carried out by PCR using AmpliTaq polymerase 
(Perkin-Elmer/AH Diagnosis, Arhus. Denmark) and primers #3 and 
#4 (50 pmol each, see Table I). For the 3’ RACE, the single strand 
cDNAs were directly used as template. PCR was carried out with 
primers #l and #2 (50 pmol each, see Table 1). 
2.2. DNA analysis 
PCR products were examined by electrophoresis n 1% agarose gel 
with ethidium bromide staining and southern blot analysis. After de- 
naturation within the agarose gel, DNA was transferred under vacuum 
to a nitrocellulose membrane (Schleicher and Schuell) and then immo- 
bilized at 80°C for 2 h. Membranes were soaked for 1 h at 65°C in a 
prehybridization solution of 5 x SSC, 10 x Denhardt’s solution, 100 
&ml salmon sperm DNA, 0.5% SDS, 10 mM EDTA then hybridized 
overnight at 65°C with “P-1abelled probe (1 x IO6 cpm per ml of prehy- 
bridization solution). Post-hybridization membranes were washed 
twice for 20 min at 65°C in 6 x SSC. The radioactive probe was gener- 
ated from a GPL cDNA fragment of 600 bp isolated in a previous work 
[6]. Labelling was performed with [a-“PI-dCTP using the Klenow 
polymerase (New England Biolabs/Finnzymes, Espoo, Finland) and a 
random hexameric primer (Pharmacia LKB, Copenhagen, Denmark). 
The labelling procedure as well as other molecular biology procedures 
were taken from [15]. 
2.3. Cloning and sequencing of GPL cDNA ends 
PCR products hybridizing with the GPL specific probe were isolated 
from 1% agarose gel and purified using the Geneclean kit (BIO 101 Inc., 
La Jolla. CA). The purified 3’ and 5’ DNA ends were then digested by 
ClaI and EcoRI endonucleases (New England BiolabslFinnzymes, 
Espoo, Finland) for cloning into the pBluescript SK II vector (Strat- 
agene, La Jolla, CA). ElectroMAX DHlOB cells were transformed by 
electroporation as described by the supplier (Life Technologies, Gaith- 
ersburg, MD) and plasmid DNAs were isolated from appropriate 
clones according to [ 151. DNA sequences were determined by the dide- 
oxynucleotide chain-termination method [16] using alkalinedenatu- 
rated plasmid DNAs and the Sequenase version 2.0 kit (US Biochemi- 
cal, Cleveland, OH). 
3. Results 
Using the RACE protocol (Fig. l), the 3’ and 5’ ends 
of GPL cDNA were amplified separately starting from 
total mRNA of guinea pig pancreas. For this purpose, 
we synthesized sense and anti-sense oligonucleotides (#2 
and # 4, see Table 1) corresponding to an internal region 
of the GPL coding sequence (see Fig. 2). A partial GPL 
cDNA clone was isolated previously during the cloning 
of GPLRP2 cDNA [6]. From sequence alignment with 
other classical pancreatic lipases, this partial cDNA of 
600 bp was found to include the lid domain coding se- 
quence. Our strategy was then to design primers in this 
region in order to amplify specifically GPL cDNA and 
not GPLRP2 in which the lid domain is deleted. There 
was still the possibility that the primers would anneal to 
a PLRPl cDNA, but we never observed any clone corre- 
sponding to a lipase of the RPl type. 
For cloning purpose, a CZul restriction site was intro- 
duced in primers #2 and #4 by substituting A by C in 
the codon corresponding to Ile-249 (see Fig. 2 and 
Table 1). Other restriction sites were introduced at the 5’ 
and 3’ ends by using primers #l and #3, respectively 
(Table 1). 
1. Reverse transcription 
cDNA (-) strand 
2. cDNA tailing 
-CCCC (-) strand l-n-n- #I 
3. Amplification of 5’ end by PCR 
I #3 GGGGI- 
CCCC (-) strand Trl-rr #I 
#3 GGGG (+) strand 
CCCC (-) strand 
4. Amplification of 3’ end by PCR 
El- 
(-) strand l-n-I-r #I 
I 
---n-n-r #I 
AAAAA 
TTTrT #I 
Fig. 1. Schematic diagram for rapid amplification of the 3’ and 5’ cDNA 
ends (RACE) of GPL. The oligonucleotides primers #I to #4 are 
described in Table 1. Dark boxes indicate DNA sequence correspond- 
ing to the lipase lid domain. 
RACE PCRs were carried out for 40 cycles with de- 
naturation, annealing and extension temperatures of 
94°C (1 min), 55°C (2 min) and 72°C (2 min), respec- 
tively. The PCR products were separated by electropho- 
resis and examined by southern blot using the partial 
GPL cDNA as a probe. A clear hybridization was ob- 
served with bands of around 1000 and 750 bp, corre- 
sponding to the 5’ and 3’ ends, respectively. These DNAs 
were cut from a preparative agarose gel stained with 
ethidium bromide, purified, digested by CZuI and EcoRI 
endonucleases, and ligated into the pBluescript SK II 
vector for transformation of E. coli electro-competent 
cells. Several clones were isolated and characterized. 
Concerning the 3’ end, several plasmid DNAs digested 
with CZuI and EcoR I were found to contain an insert of 
730 bp. One of them was sequenced on both strands and 
a second on one strand to check that mutations were not 
introduced by Taq polymerase during the PCR reaction. 
Fig. 2. cDNA and amino acid sequence of the classical guinea pig pancreatic lipase (GPL). Numbering of nucleotides begins and ends at the CIaI 
and EcoRI restriction sites, respectively. Numbering of amino acid residues begins at the signal peptide. The signal peptide cleavage site is shown 
by an arrow. The positions of primers #2 and #4 are shown and the star indicates the point mutation for introducing a CIaI restriction site (see Table 
I). Letters in italics indicate the nucleotide sequence corresponding to primer #l and letters in bold indicate the pB1uescript SK II vector sequence. 
Concerning the 5’ end, it appeared that ClaI was also 
cutting GPL cDNA at around 200 bp upstream of the 
coding sequence (see Fig. 2) generating aDNA fragment 
of 990 bp. After cloning in the ClaI restriction site of the 
pBluescript KS II vector, an insert of the same size was 
found in several clones and two of them were sequenced. 
The complete sequence of GPL cDNA was then as- 
sembled as shown in Fig. 2. 
4. Discussion 
From sequence alignment with all the known PLs [4- 
8,17-221, it is clear that the GPL sequence reported here 
corresponds to a classical PL (data not shown). GPL 
possesses 76.2% of amino acid identities with the classi- 
cal HPL whereas it only shares 60.1% of amino acid 
identities with GPLRP2 (Fig. 3). When the N- and C- 
Table 1 
Oligonucleotides used as primers for cloning GPL cDNA 
NO Oligonucleotide 
#1 GAG AGA GAA TTC TCT AGA CTC GAG T,, 
Comment 
Anti-sense primer for first strand cDNA synthesis and 3’ RACE. 
Restriction sites: EcoRI, XbaI, XhoI 
#2 GTT GAC ATC GAT GGA ATC TGG GAA Sense primer for 3’ RACE 
Restriction site: ClaI 
#3 CGA GAA TTC GGA TCC G,, Sense primer for 5’ RACE 
Restriction sites: EcoRI, BamHI 
#4 GAT TCC ATC GAT GTC AAC AAT CTG Anti-sense primer for 5’ RACE 
Restriction site: ClaI 
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HPL 
GPL 
GPLRPZ 
HPL 
GPL 
GPLRPZ 
HPL 
GPL 
GPLRP2 
HPL 
GPL 
GPLRP2 
HPL 
GPL 
GPLRP2 
HPL 
GPL 
GPLRP2 
HPL 
GPL 
GPLRP2 
c N-terminal 
HPL 
GPL 
GPLRP2 
HPL 
GPL 
GPLRP2 
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100 
DSSsIsgSNPKTNRATRPIIROIIDK(;IEENWLAnVCIC 
DSSVIrsSdPKTdRKTRIIIaalIDKOIENOJLADlClQ 
DiatIkaSNPnlNRXTRFIIHQPtDsQ~ns~LsDmC1WmPQVkk~CICVD~QQ 
Lps IoopJ 
150 o 
SRTgYtQASQIIRiVQA16VAYfVeFLQSafgYsPSNVHRR 
SRTlYSQASQIIqWQAEVAYLinFLQSqLdYpPSsVllIIQHSMsHAAQEAQRR 
8kaqYSQASQIIRWQArVAYLVqvLstsLnYaPeNVII:IIQHSLQAR:tAQ~AQkR 
200 
0 
TIQtIQRITQLDPAEPcFQgTPElVRLDPSDAKrVOVIHTDGaPQPQMsQ 
TarQaIQRITQLDPAlePYPQyTPriVVRLDPSDAqPVDVIHTDGnPIIPNLQPQMSQ 
1sQlvQRITQLDPAIPYPQdTP~eVRLDPSDAKPVDVI~TDisPIlPsLQTQMSQ 
250 
* * * 0 
VVQHLDFPP~~"eMPQCKKNILSQ~V~~~G=~RG~R~F~C~LRSYKYYt~S= 
tVQ~LDPPP~~lqMPQCqKNILSQIVDIDGIWEGTRDFARSYKYYiDSI 
kVQ~DFFP1WkdlilPQCKtgIs--------------------C~hRsieYYhsSI 
I Lid domain A 
300 
~PdQFAQFPCASYnvFtaNKCFPCPsGGCPQMQRYADrYPQKTNdVgQkFYLdT 
tlPkQFAQFsCdSYssPssNKCFPCatGeCPQYQlIYADkfPQKTkenfQNFYLNT 
11PeQFlQyPCASYdePqesgCFPCPakGCPkMQAfADqYPQATNaVeQtFfLNT 
350 
* **** 
QDaSlPaRWRYKVsVTLSQkK-VTQHILVSLFQnkQNSKQYEIFKQTLKPDstHSN 
QDkSNFsR~YriaVTLSQqK-VTQHvLVSLFQdaQNtKQYEIyrQsLKPgnnHSN 
QasdNFtR~YKVtVTLSQeKdpsQnInVaLlGknGNSaQYqvFKGTLKPD~sYtN 
domain 1 LC-terminal domain- 
400 
** *** 
EfDSDVDVGDLQmVKPI~NNVINpTLPrVMSkIiVetn-vQkqFNPCSPeTVRE 
EIDSDVDVaDLQKVKFIPrYNNVIN~TLPKVMSRI~trs-DGrVFdFCsqDTVRE 
sIDvelnVGtiQKVtFlWkrsgIsvskPKmQASRITVqsgkDGtkyNFCSsDiVqE 
450 
** 
EVLLTLtPC 
EVLLTLqPC 
nVeqTLsPC 
Fig. 3. Amino acid sequence alignment of GPL with HPL and GPLRP2. HPL and GPLRPZ sequences are based on ref. [1,19] and [6], respectively. 
Active site residues (Ser-1.52, Asp-176, His-263) are shown by open circles. Stars indicate amino acids involved in colipase binding to HPL [2]. The 
positions of the b5 loop, the lid domain and the junction between the N- and C-terminal domains are shown. Capital letters in bold indicate amino 
acid residues conserved within the three lipases. 
terminal domains of GPL and HPL are compared inde- 
pendently, it appears that the level of amino acid identi- 
ties are similar (77.4 and 72.6%, respectively). A similar 
comparison between GPL and GPLRP2 reveals that the 
N-terminal domain (with the exception of the lid do- 
main) is much more conserved (68.7%) than the C-termi- 
nal domain (48.7%). Globally, the domains involved in 
the high specificity of classical PLs towards triglycerides 
through the binding of colipase are well conserved in 
GPL and are extensively mutated in GPLRP2. 
The lid domain is involved in the interfacial activation 
of classical PL. In the absence of an aggregated lipid 
substrate, the lid domain prevents the access to the active 
site [l]. In the presence of a water/lipid interface, the lid 
domain as well as another surface loop (the so-called b5 
loop) undergo large conformational changes thus open- 
ing access to the active site and creating the oxyanion 
hole [3]. The new conformation of the lid domain is 
stabilized by interactions with the protein core and the 
b5 loop (Table 2). The colipase interacts with both the 
lid and the lipase C-terminal domain (Table 2). All the 
lipase amino acid residues involved in the previous inter- 
actions are well conserved within the classical PL sub- 
family, and this is also the case for GPL (see Fig. 3 and 
Table 2). 
In GPLRPZ, these functional amino acid residues are 
nearly all mutated. The lid domain of 23 residues in GPL 
and HPL (between Cys-237 and Cys-261) is replaced by 
a short loop of 5 residues in GPLRP2 (Fig. 3). The lid 
interactions as observed in HPL cannot exist and the 
E Carrit?re et al. IFEBS Letters 338 (1994) 63-68 
Hydrophobic 
Hydrophilic 
GPL 
Fig. 4. Schematic diagram representing the distinct biological functions of GPL and GPLRP2. GPL model is based on 
complex [2]. GPLRP2 model is based on HPL 3D structure [6]. TG is the abbreviation for triglycerides. 
Table 2 
Conservation of the functional amino acids found in HPL-colipase 
complex. Numbering is based on ref. [l]. 
Interactions HPL GPL GPLRPZ 
Lid/protein core 
Lid@5 loop 
Arg-256...Tyr-267 
Asp-257...Lys-268 
Trp-252...Glu-83 
Arg-256...Asp-79 
ArglTyr -/I& 
AsplLys _ -/Glu 
Trp/Glu -lAsn 
Arg/Asp -1X$ 
Lidkolipase 
C-terminal domain/ 
colipase 
Asn-240 
Ser-243 
Val-246 
Phe-360 
Asn-365 
Ser-366 
Lys-367 
Gin-368 
Asp-389 
Val-390 
Lys-399 
Ile-401 
Tyr-403 
Glu-44 1 
Leu-443 
Asn - 
Ser - 
Val - 
Phe LeU 
Asn Asn 
Thr Ser 
Lys Ala - 
Gln Gln 
Asp Glu 
Val Leu 
Lys _ Thr 
Ile g 
Tyr k 
Glu Asn 
Leu Glu 
61 
GPLRP2 
the Ca tracing of HPL-colipase 
corresponding amino acids in the protein core and the 
b5 loop are also different (Table 2). The lid/colipase 
interactions are suppressed and among the twelve resi- 
dues identified as the colipase binding site in the C- 
terminal domain of HPL, nine are different in GPLRP2 
(Fig. 3 and Table 2). 
Even though GPL has not been expressed and enzy- 
matically characterized, it is probably this pancreatic 
enzyme which is responsible for dietary triglyceride hy- 
drolysis in the guinea pig intestine, like HPL in humans. 
On the contrary, the kinetic properties of GPLRP2 have 
been studied in vitro [6,8]. This atypical PL is character- 
ized by (1) an absence of interfacial activation, (2) an 
inhibition by bile salts of the lipase activity towards in- 
soluble triglycerides, (3) an absence of colipase effect, 
and finally (4) a high phospholipase activity towards 
phospholipids found in mixed micelles. Whereas the ab- 
sences of interfacial activation and colipase binding can 
be easily interpreted from the previous structural analy- 
sis, the reasons for GPLRP2 phospholipase activity re- 
main unknown. In the GPLRP2 model based on HPL 
3D structure, there is a high degree of conservation of the 
68 E: Can-i&-e et al. IFEBS Letters 338 (1994) 63-68 
amino acid residues found in a 10 A radius sphere from 
the active site Ser-152 [6]. The classical PLs are however 
completely inactive towards phospholipids found in 
mixed micelles and can only hydrolyze monolayers of 
negatively charged phospholipids at a very low rate [23]. 
In conclusion, GPL and GPLRP2 presumably have 
two distinct physiological roles in the intestine, where the 
triglyceride droplets are covered by bile salts and the 
phospholipids are mainly present in mixed micelles: GPL 
is a triglyceride hydrolase and GPLRP2 is a phospho- 
glyceride hydrolase (Fig. 4). The role of GPLRP2 as a 
physiologically important phospholipase is supported by 
the absence of any measurable phospholipase A2 activity 
in the guinea pig pancreas [93, even though it has been 
shown recently that a phospholipase A2 of the pancreatic 
type is produced by the guinea pig stomach [24.25]. 
The comparison of classical and RP2 pancreatic li- 
pases provides an excellent ool for futher investigation 
of structure/function relationships including substrate 
specificity and more generally, lipid/protein interactions. 
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